The move aimed at helping boost production as demand currently outstrips supply.
“The agreement will see Novartis utilizing its aseptic manufacturing facilities at its site in Stein, Switzerland,” Novartis said in a statement on Friday. External link
“Subject to reaching a final agreement, Novartis plans to commence production in the second quarter of 2021.”
This is the first of multiple agreements “to leverage manufacturing capacity and capabilities to address pandemic, supporting global supply of Covid-19 vaccine” being explored by Novartis, the company said.
The Pfizer-BioNTech Covid-19 Vaccine has been authorised for use by the health regulatory authorities of about 50 countries, including Switzerland. It has also received authorisations for emergency use countries like the United Kingdom and the United States.
Switzerland will be affected by the temporary delay to the Pfizer-BioNTech Covid-19 vaccine in Europe, the Swiss health authorities have already confirmed.
Moderna has warned Switzerland that its Covid-19 vaccine deliveries would be delayed, the Swiss Federal Office of Public Health said on Thursday. This will lead to a shortfall in February that the Swiss expect the US company to make up in March, Reuters has reported.External link
Popular Stories
More
Life & Aging
Zurich: how the world capital of housing shortages is tackling the problem
This content was published on
Swiss International Air Lines will avoid Pakistani airspace until further notice due to rising tension between India and Pakistan.
Swiss defence minister reaffirms military cooperation with neighbours
This content was published on
On his first trip abroad in government, Defence Minister Martin Pfister visited the Swiss troops taking part in a major exercise in Austria.
Trade unions mobilise against right-wing extremist circles
This content was published on
Under the motto 'Solidarity instead of agitation - strong together!' May Day events are taking place throughout Switzerland this Thursday.
This content was published on
Switzerland will be affected by the temporary delay to the Pfizer-BioNTech Covid-19 vaccine in Europe, the Swiss health authorities have confirmed.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.